Tradestie Institutional Equity Comparison Engine

ABFL vs SPXV โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SPXV Overall Edge

SPXV Captures Institutional Edge (1โ€“1 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProShares S&P 500 Ex-Health Care ETF (SPXV) driven by superior Momentum & Technical while ABFL counters with relative strength in Options & Structure. Fundamentally, ABFL trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SPXV at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABFL sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against SPXV sits in UNCLASSIFIED (92nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ABFL N/M vs SPXV N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner SPXV
1Y +0.4% vs +1.2% ยท 52W Pos 10% vs 31%
Options & Structure Winner ABFL
UNCLASSIFIED (50th %ile IV) vs UNCLASSIFIED (92nd %ile IV)
ABFL Cboe BZX
Abacus FCF Leaders ETF
Institutional Equity
$69.81
-2.63% 1D
Market Cap N/A
1M Return -11.59%
1Y Return +0.4%
Forward P/E N/M
Unified AI Score
36.4 / 100 SELL
Tech 16.0 Fund 34.0 Flow 50.0 Mom 45.0
SPXV NYSE Arca
ProShares S&P 500 Ex-Health Care ETF
Institutional Equity
$74.11
-4.37% 1D
Market Cap N/A
1M Return -10.69%
1Y Return +1.17%
Forward P/E N/M
Unified AI Score
39.6 / 100 SELL
Tech 13.0 Fund 50.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABFL +0.4% SPXV +1.17% Spread: +2.15 pp (SPXV Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABFL TTM Op. Margin: N/A SPXV TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABFL vs SPXV. Trailing 12-month operating profitability (ABFL N/A vs SPXV N/A) and valuation multiples (ABFL N/M vs SPXV N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABFL (1) vs SPXV (2)
Institutional Metric ABFL SPXV Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 10% ($68โ€“$86) 31% ($69โ€“$86) Stronger Trend SPXV
Beta / 30D Volatility Risk Regime 1.00ฮฒ ยท 24% Vol 1.04ฮฒ ยท 25% Vol Lower Realized Risk ABFL
Unified Institutional Score Composite Signal 36.4 / 100 (SELL) 39.6 / 100 (SELL) Higher Composite SPXV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABFL vs SPXV Buy Guide
ABFL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABFL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SPXV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 92nd %ile
IV Regime Extreme (>80th %ile)
Live SPXV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABFL nor SPXV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.